{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:40:05Z","timestamp":1794321605730,"version":"4.9.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The <jats:italic>PDCD1<\/jats:italic>-encoded immune checkpoint receptor PD-1 is a key tumor suppressor in T cells that is recurrently inactivated in T cell non-Hodgkin lymphomas (T-NHLs). The highest frequencies of <jats:italic>PDCD1<\/jats:italic> deletions are detected in advanced disease, predicting inferior prognosis. However, the tumor-suppressive mechanisms of PD-1 signaling remain unknown. Here, using tractable mouse models for T-NHL and primary patient samples, we demonstrate that PD-1 signaling suppresses T cell malignancy by restricting glycolytic energy and acetyl coenzyme A (CoA) production. In addition, PD-1 inactivation enforces ATP citrate lyase (ACLY) activity, which generates extramitochondrial acetyl-CoA for histone acetylation to enable hyperactivity of activating protein 1 (AP-1) transcription factors. Conversely, pharmacological ACLY inhibition impedes aberrant AP-1 signaling in PD-1-deficient T-NHLs and is toxic to these cancers. Our data uncover genotype-specific vulnerabilities in <jats:italic>PDCD1<\/jats:italic>-mutated T-NHL and identify PD-1 as regulator of AP-1 activity.<\/jats:p>","DOI":"10.1038\/s43018-023-00635-7","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T16:02:01Z","timestamp":1695052921000},"page":"1508-1525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma"],"prefix":"10.1038","volume":"4","author":[{"given":"Tim","family":"Wartewig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-6795","authenticated-orcid":false,"given":"Jay","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Hameister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Morrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-8741","authenticated-orcid":false,"given":"Anuroop V.","family":"Venkatasubramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-3436","authenticated-orcid":false,"given":"Filippo M.","family":"Cernilogar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-5189","authenticated-orcid":false,"given":"Frits H. A.","family":"van Heijster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hundshammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith V.","family":"Gabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1446-3703","authenticated-orcid":false,"given":"Christine","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-6893","authenticated-orcid":false,"given":"Henry","family":"Kurniawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-0085","authenticated-orcid":false,"given":"Calvin","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-8565","authenticated-orcid":false,"given":"Yujin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-907X","authenticated-orcid":false,"given":"Ignasi","family":"Forne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Giustinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-8613","authenticated-orcid":false,"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvia","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-9659","authenticated-orcid":false,"given":"Roland","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-4628","authenticated-orcid":false,"given":"Franz","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Schotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2993-8249","authenticated-orcid":false,"given":"Axel","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-1045","authenticated-orcid":false,"given":"Dirk","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-2226","authenticated-orcid":false,"given":"Jaehyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-3597","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Ruland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"635_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","volume":"20","author":"D Fiore","year":"2020","unstructured":"Fiore, D. et al. Peripheral T cell lymphomas: from the bench to the clinic. Nat. Rev. Cancer 20, 323\u2013342 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"635_CR2","doi-asserted-by":"crossref","unstructured":"Park, J. et al. Integrated genomic analyses of cutaneous T cell lymphomas reveal the molecular bases for disease heterogeneity. Blood 138, 1225\u20131236 (2021).","DOI":"10.1182\/blood.2020009655"},{"key":"635_CR3","doi-asserted-by":"publisher","first-page":"e000104","DOI":"10.1136\/jitc-2019-000104","volume":"8","author":"K Anand","year":"2020","unstructured":"Anand, K. et al. T-cell lymphoma secondary to checkpoint inhibitor therapy. J. Immunother. Cancer 8, e000104 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"635_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jdcr.2020.12.033","volume":"9","author":"JA Marks","year":"2021","unstructured":"Marks, J. A., Parker, D. C., Garrot, L. C. & Lechowicz, M. J. Nivolumab-associated cutaneous T-cell lymphoma. JAAD Case Rep. 9, 39\u201341 (2021).","journal-title":"JAAD Case Rep."},{"key":"635_CR5","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood.2019002038","volume":"134","author":"DA Rauch","year":"2019","unstructured":"Rauch, D. A. et al. Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating Tregs after PD-1 blockade. Blood 134, 1406\u20131414 (2019).","journal-title":"Blood"},{"key":"635_CR6","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1056\/NEJMc1803181","volume":"378","author":"L Ratner","year":"2018","unstructured":"Ratner, L., Waldmann, T. A., Janakiram, M. & Brammer, J. E. Rapid progression of adult T-cell leukemia-lymphoma after PD-1 inhibitor therapy. N. Engl. J. Med. 378, 1947\u20131948 (2018).","journal-title":"N. Engl. J. Med."},{"key":"635_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1182\/blood-2019-126194","volume":"134","author":"NN Bennani","year":"2019","unstructured":"Bennani, N. N. et al. A phase II study of nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma. Blood 134, 467 (2019).","journal-title":"Blood"},{"key":"635_CR8","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1128\/MCB.00319-13","volume":"33","author":"N Patsoukis","year":"2013","unstructured":"Patsoukis, N., Li, L., Sari, D., Petkova, V. & Boussiotis, V. A. PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2. Mol. Cell. Biol. 33, 3091\u20133098 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"635_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"635_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001\u20131012 (2020).","journal-title":"Nat. Metab."},{"key":"635_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff, K. et al. The fusion kinase ITK\u2013SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J. Exp. Med. 207, 1031\u20131044 (2010).","journal-title":"J. Exp. Med."},{"key":"635_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature24649","volume":"552","author":"T Wartewig","year":"2017","unstructured":"Wartewig, T. et al. PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis. Nature 552, 121\u2013125 (2017).","journal-title":"Nature"},{"key":"635_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325\u2013338 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"635_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-26","volume":"6","author":"F Luo","year":"2006","unstructured":"Luo, F. et al. Hypoxia-inducible transcription factor-1\u03b1 promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway. BMC Cancer 6, 26 (2006).","journal-title":"BMC Cancer"},{"key":"635_CR15","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1182\/blood-2010-10-314427","volume":"117","author":"J Schodel","year":"2011","unstructured":"Schodel, J. et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP\u2013seq. Blood 117, e207\u2013e217 (2011).","journal-title":"Blood"},{"key":"635_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10334-019-00807-6","volume":"33","author":"GJ Topping","year":"2020","unstructured":"Topping, G. J. et al. Acquisition strategies for spatially resolved magnetic resonance detection of hyperpolarized nuclei. MAGMA 33, 221\u2013256 (2020).","journal-title":"MAGMA"},{"key":"635_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"635_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg effect: how does it benefit cancer cells? Trends Biochem. Sci 41, 211\u2013218 (2016).","journal-title":"Trends Biochem. Sci"},{"key":"635_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/BF01504608","volume":"12","author":"O Warburg","year":"1924","unstructured":"Warburg, O. \u00dcber den Stoffwechsel der Carcinomzelle. Naturwissenschaften 12, 1131\u20131137 (1924).","journal-title":"Naturwissenschaften"},{"key":"635_CR20","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R. & Tee, A. R. mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34, 2239\u20132250 (2015).","journal-title":"Oncogene"},{"key":"635_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","volume":"19","author":"M Muschen","year":"2019","unstructured":"Muschen, M. Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nat. Rev. Immunol. 19, 337\u2013348 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"635_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-61779-430-8_29","volume":"821","author":"Q Liu","year":"2012","unstructured":"Liu, Q. et al. Development of ATP-competitive mTOR inhibitors. Methods Mol. Biol. 821, 447\u2013460 (2012).","journal-title":"Methods Mol. Biol."},{"key":"635_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","volume":"3","author":"S Welsh","year":"2004","unstructured":"Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G. & Powis, G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1\u03b1. Mol. Cancer Ther. 3, 233\u2013244 (2004).","journal-title":"Mol. Cancer Ther."},{"key":"635_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41596-018-0102-x","volume":"14","author":"M Yuan","year":"2019","unstructured":"Yuan, M. et al. Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC\u2013MS\/MS. Nat. Protoc. 14, 313\u2013330 (2019).","journal-title":"Nat. Protoc."},{"key":"635_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis, R. J. & Chandel, N. S. We need to talk about the Warburg effect. Nat. Metab. 2, 127\u2013129 (2020).","journal-title":"Nat. Metab."},{"key":"635_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrc.2016.82","volume":"16","author":"A Kinnaird","year":"2016","unstructured":"Kinnaird, A., Zhao, S., Wellen, K. E. & Michelakis, E. D. Metabolic control of epigenetics in cancer. Nat. Rev. Cancer 16, 694\u2013707 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"635_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.aaf6284","volume":"354","author":"M Peng","year":"2016","unstructured":"Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481\u2013484 (2016).","journal-title":"Science"},{"key":"635_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tibs.2017.11.004","volume":"43","author":"S Sivanand","year":"2018","unstructured":"Sivanand, S., Viney, I. & Wellen, K. E. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation. Trends Biochem. Sci. 43, 61\u201374 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"635_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076\u20131080 (2009).","journal-title":"Science"},{"key":"635_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molcel.2018.07.015","volume":"71","author":"SL Campbell","year":"2018","unstructured":"Campbell, S. L. & Wellen, K. E. Metabolic signaling to the nucleus in cancer. Mol. Cell 71, 398\u2013408 (2018).","journal-title":"Mol. Cell"},{"key":"635_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40170-015-0135-3","volume":"3","author":"AA Cluntun","year":"2015","unstructured":"Cluntun, A. A. et al. The rate of glycolysis quantitatively mediates specific histone acetylation sites. Cancer Metab. 3, 10 (2015).","journal-title":"Cancer Metab."},{"key":"635_CR32","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.bmcl.2007.03.017","volume":"17","author":"JJ Li","year":"2007","unstructured":"Li, J. J. et al. 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg. Med. Chem. Lett. 17, 3208\u20133211 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"635_CR33","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1002\/cpps.54","volume":"92","author":"MC Volker-Albert","year":"2018","unstructured":"Volker-Albert, M. C., Schmidt, A., Forne, I. & Imhof, A. Analysis of histone modifications by mass spectrometry. Curr. Protoc. Protein Sci. 92, e54 (2018).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"635_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","volume":"471","author":"P Icard","year":"2020","unstructured":"Icard, P. et al. ATP citrate lyase: a central metabolic enzyme in cancer. Cancer Lett. 471, 125\u2013134 (2020).","journal-title":"Cancer Lett."},{"key":"635_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306\u2013319 (2014).","journal-title":"Cell Metab."},{"key":"635_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14430-w","volume":"11","author":"C Martinez Calejman","year":"2020","unstructured":"Martinez Calejman, C. et al. mTORC2\u2013AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. Nat. Commun. 11, 575 (2020).","journal-title":"Nat. Commun."},{"key":"635_CR37","doi-asserted-by":"publisher","first-page":"e11612","DOI":"10.7554\/eLife.11612","volume":"5","author":"AJ Covarrubias","year":"2016","unstructured":"Covarrubias, A. J. et al. Akt\u2013mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. eLife 5, e11612 (2016).","journal-title":"eLife"},{"key":"635_CR38","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita, T. et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 68, 8547\u20138554 (2008).","journal-title":"Cancer Res."},{"key":"635_CR39","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/bi992159y","volume":"39","author":"IA Potapova","year":"2000","unstructured":"Potapova, I. A., El-Maghrabi, M. R., Doronin, S. V. & Benjamin, W. B. Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. Biochemistry 39, 1169\u20131179 (2000).","journal-title":"Biochemistry"},{"key":"635_CR40","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","volume":"269","author":"CJ Vlahos","year":"1994","unstructured":"Vlahos, C. J., Matter, W. F., Hui, K. Y. & Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241\u20135248 (1994).","journal-title":"J. Biol. Chem."},{"key":"635_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nmeth0807-613","volume":"4","author":"ER Mardis","year":"2007","unstructured":"Mardis, E. R. ChIP\u2013seq: welcome to the new frontier. Nat. Methods 4, 613\u2013614 (2007).","journal-title":"Nat. Methods"},{"key":"635_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s000180050121","volume":"54","author":"CA Mizzen","year":"1998","unstructured":"Mizzen, C. A. & Allis, C. D. Linking histone acetylation to transcriptional regulation. Cell. Mol. Life Sci. 54, 6\u201320 (1998).","journal-title":"Cell. Mol. Life Sci."},{"key":"635_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2004.05.023","volume":"117","author":"SK Kurdistani","year":"2004","unstructured":"Kurdistani, S. K., Tavazoie, S. & Grunstein, M. Mapping global histone acetylation patterns to gene expression. Cell 117, 721\u2013733 (2004).","journal-title":"Cell"},{"key":"635_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"635_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1642-2","volume":"20","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Identification of transcription factor binding sites using ATAC-seq. Genome Biol. 20, 45 (2019).","journal-title":"Genome Biol."},{"key":"635_CR46","doi-asserted-by":"crossref","first-page":"D87","DOI":"10.1093\/nar\/gkaa516","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes, O. et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 48, D87\u2013D92 (2020).","journal-title":"Nucleic Acids Res."},{"key":"635_CR47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"635_CR48","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1093\/nar\/gku463","volume":"42","author":"RP Welch","year":"2014","unstructured":"Welch, R. P. et al. ChIP-Enrich: gene set enrichment testing for ChIP\u2013seq data. Nucleic Acids Res. 42, e105 (2014).","journal-title":"Nucleic Acids Res."},{"key":"635_CR49","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"635_CR50","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1105136","volume":"306","author":"EP Consortium","year":"2004","unstructured":"Consortium, E. P. The ENCODE (Encyclopedia of DNA Elements) Project. Science 306, 636\u2013640 (2004).","journal-title":"Science"},{"key":"635_CR51","doi-asserted-by":"publisher","first-page":"baw100","DOI":"10.1093\/database\/baw100","volume":"2016","author":"AD Rouillard","year":"2016","unstructured":"Rouillard, A. D. et al. The Harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database 2016, baw100 (2016).","journal-title":"Database"},{"key":"635_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"RJ Davis","year":"2000","unstructured":"Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239\u2013252 (2000).","journal-title":"Cell"},{"key":"635_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2006.08.005","volume":"24","author":"T Sasaki","year":"2006","unstructured":"Sasaki, T. et al. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol. Cell 24, 63\u201375 (2006).","journal-title":"Mol. Cell"},{"key":"635_CR54","doi-asserted-by":"publisher","first-page":"22770","DOI":"10.1016\/S0021-9258(18)54634-2","volume":"266","author":"S Ferrari","year":"1991","unstructured":"Ferrari, S., Bandi, H. R., Hofsteenge, J., Bussian, B. M. & Thomas, G. Mitogen-activated 70K S6 kinase. Identification of in vitro 40 S ribosomal S6 phosphorylation sites. J. Biol. Chem. 266, 22770\u201322775 (1991).","journal-title":"J. Biol. Chem."},{"key":"635_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nprot.2007.76","volume":"2","author":"K Yamada","year":"2007","unstructured":"Yamada, K., Saito, M., Matsuoka, H. & Inagaki, N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nat. Protoc. 2, 753\u2013762 (2007).","journal-title":"Nat. Protoc."},{"key":"635_CR56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/annonc\/mdv624","volume":"27","author":"SJ Kim","year":"2016","unstructured":"Kim, S. J. et al. A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas. Ann. Oncol. 27, 712\u2013718 (2016).","journal-title":"Ann. Oncol."},{"key":"635_CR57","doi-asserted-by":"publisher","first-page":"e20182009","DOI":"10.1084\/jem.20182009","volume":"217","author":"M Yukawa","year":"2020","unstructured":"Yukawa, M. et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J. Exp. Med. 217, e20182009 (2020).","journal-title":"J. Exp. Med."},{"key":"635_CR58","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576, 293\u2013300 (2019).","journal-title":"Nature"},{"key":"635_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2017.05.008","volume":"32","author":"K Qu","year":"2017","unstructured":"Qu, K. et al. Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC inhibitors. Cancer Cell 32, 27\u201341 (2017).","journal-title":"Cancer Cell"},{"key":"635_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep25533","volume":"6","author":"S Parekh","year":"2016","unstructured":"Parekh, S., Ziegenhain, C., Vieth, B., Enard, W. & Hellmann, I. The impact of amplification on differential expression analyses by RNA-seq. Sci. Rep. 6, 25533 (2016).","journal-title":"Sci. Rep."},{"key":"635_CR61","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"635_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"635_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"635_CR64","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"635_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"635_CR66","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nprot.2007.202","volume":"2","author":"D Shechter","year":"2007","unstructured":"Shechter, D., Dormann, H. L., Allis, C. D. & Hake, S. B. Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445\u20131457 (2007).","journal-title":"Nat. Protoc."},{"key":"635_CR67","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nprot.2012.024","volume":"7","author":"M Yuan","year":"2012","unstructured":"Yuan, M., Breitkopf, S. B., Yang, X. & Asara, J. M. A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7, 872\u2013881 (2012).","journal-title":"Nat. Protoc."},{"key":"635_CR68","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"635_CR69","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","volume":"51","author":"MA Lauterbach","year":"2019","unstructured":"Lauterbach, M. A. et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity 51, 997\u20131011 (2019).","journal-title":"Immunity"},{"key":"635_CR70","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1093\/nar\/gkz627","volume":"47","author":"FM Cernilogar","year":"2019","unstructured":"Cernilogar, F. M. et al. Pre-marked chromatin and transcription factor co-binding shape the pioneering activity of Foxa2. Nucleic Acids Res. 47, 9069\u20139086 (2019).","journal-title":"Nucleic Acids Res."},{"key":"635_CR71","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"635_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"635_CR73","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"635_CR74","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).","journal-title":"Bioinformatics"},{"key":"635_CR75","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"635_CR76","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/nprot.2012.101","volume":"7","author":"J Feng","year":"2012","unstructured":"Feng, J., Liu, T., Qin, B., Zhang, Y. & Liu, X. S. Identifying ChIP\u2013seq enrichment using MACS. Nat. Protoc. 7, 1728\u20131740 (2012).","journal-title":"Nat. Protoc."},{"key":"635_CR77","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi, J. et al. Genomic landscape of cutaneous T cell lymphoma. Nat. Genet. 47, 1011\u20131019 (2015).","journal-title":"Nat. Genet."},{"key":"635_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15572-7","volume":"11","author":"J Daniels","year":"2020","unstructured":"Daniels, J. et al. Cellular origins and genetic landscape of cutaneous \u03b3 \u03b4 T cell lymphomas. Nat. Commun. 11, 1806 (2020).","journal-title":"Nat. Commun."},{"key":"635_CR79","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"635_CR80","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"635_CR81","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"635_CR82","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-023-00635-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-023-00635-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-023-00635-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T07:05:02Z","timestamp":1698217502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-023-00635-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1038\/s43018-023-00635-7","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.W., J.D., J.C. and J.R. are listed as inventors on a patent application related to this work. The other authors declare no competing interests. D.M.W. is an employee of MSD\u2013Merck. He has equity interest in Travera, Ajax and Bantam.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}